Morphine treatment during rat pregnancy: neonatal and preweaning consequences

Area of Science:

• Pharmacology
• Developmental Neuroscience
• Reproductive Biology

Background:

• Opioid use during pregnancy can lead to neonatal withdrawal syndrome (NWS) in humans.
• Animal models are crucial for understanding the mechanisms and long-term consequences of prenatal drug exposure.

Purpose of the Study:

• To establish a rat model for prenatal morphine exposure.
• To investigate the occurrence and characteristics of neonatal withdrawal syndrome (NWS).
• To examine prolonged developmental and neurobehavioral effects in offspring.

Main Methods:

• Morphine administration to female rats starting before mating and continuing throughout gestation, with dose escalation.
• Observation of maternal behavior for signs of dependence and abstinence.
• Assessment of neonate respiratory rates, crying, restlessness, eye-opening time, and sexual maturation.

Main Results:

• Pregnant dams exhibited behavioral signs of morphine dependence and abstinence.
• Morphine-exposed neonates showed significantly decreased respiratory rates and increased crying and restlessness, indicative of NWS.
• Offspring experienced delayed eye-opening and earlier sexual maturation in females.

Conclusions:

• The established rat model effectively reproduces key features of human neonatal withdrawal syndrome.
• Prenatal morphine exposure has significant, lasting impacts on offspring's physical growth and neurobehavioral development.
• This model aids in studying the complex interplay between narcotic exposure and postnatal maturation.